| Name | Title | Contact Details |
|---|
Keystone Emergency Management Group is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. Led by an experienced surgeon team and utilizing patented viscoelastic polymer technology, AxioMed has developed the next generation of artificial discs.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
A new standard for virtual heart care. Heartbeat is a complete telehealth platform for cardiology that incorporates telemedicine, remote diagnostics, and digital heart health programs. Learn more
Auspex Pharmaceuticals, Inc. develops deuterated analogs of clinically-validated drugs. Its technology replaces metabolically-sensitive hydrogen atoms with its non-radioactive isotope deuterium to create therapeutics. The company was founded in 2001 and is based in La Jolla, California.